Heinz Maier-Leibnitz Prize for Maike Hofmann
Freiburg molecular physician receives most important award for young researchers in Germany / Maike Hofmann researches the human immune system at the Faculty of Medicine - University of Freiburg and the Medical Center - University of Freiburg
Immunologist Dr. Maike Hofmann has been awarded the Heinz Maier-Leibnitz Prize by the German Research Foundation (DFG). This was decided by a selection committee set up by the DFG and the Federal Ministry of Education and Research. The prize is regarded as the most important award for young scientists in Germany. It will be awarded a total of ten times this year and is endowed with 20,000 euros each. Maike Hofmann studies the human immune system.
She is a research group leader at the Department of Medicine II (Medical Director: Prof. Dr. Robert Thimme) at the Medical Center - University of Freiburg and at the Faculty of Medicine - University of Freiburg. Among other things, she is a sub-project leader in the Collaborative Research Center (CRC) 1160 "IMPATH - Immunopathology due to impaired immune responses", CRC 1479 "OncoEscape - Oncogene-driven immune escape" and TRR 179 "Determinants and dynamics of elimination versus persistence of hepatitis virus infections". In her habilitation project, Hofmann is investigating how so-called killer cells of the human immune system control viral hepatitis. These cells are a group of white blood cells that have cell-damaging properties - and play a central role in the immune response to hepatitis viruses and liver cancer cells. Since 2019, her work has been funded by the "Margarete von Wrangell Habilitation Program for Women" of the Baden-Württemberg Ministry of Science, Research and the Arts.
Publications on SARS-CoV-2
Most recently, Hofmann was significantly involved in two Freiburg studies on SARS-CoV-2. In their publications, the scientists were able to show that immune cells are formed after a SARS-CoV-2 infection - so-called memory T cells - which are retained in the body and could mediate a rapid immune response in the event of a new infection. The study was published in the journal Nature Medicine. In a second study, published in Nature, the researchers identified when an initial immune protection can be detected after SARS-CoV-2 vaccination with an mRNA-based vaccine and how the reactions of the different components of the human immune system develop over months.
Caption: Dr. Maike Hofmann
Image source: University of Freiburg / Klaus Polkowski
Contact:
Dr. Maike Hofmann
Research group leader
Department of Medicine II (focus: gastroenterology, hepatology, endocrinology and infectiology)
Uniklinik Freiburg
Phone: 0761 270-35091
maike.hofmann@uniklinik-freiburg.de
Back
Medical Center - University of Freiburg
Central Information
Phone: 0761 270-0
info@uniklinik-freiburg.de
For press inquiries:
Corporate Communications
Breisacher Straße 153
79110 Freiburg
Phone: 0761 270-84830
kommunikation@uniklinik-freiburg.de

